Showing results (2431-2440 of 2,459) with videos related to

Sort By:
Pageof 246
Therapie|August 1, 2016
[Targeting high-risk drugs to optimize clinical pharmacists' intervention]Anne-Laure Mouterde, Magali Bourdelin, Ophélie Maison, et al.
Therapie|February 25, 2023
[Does aspirin have a place in primary cardiovascular prevention by the polypill ? Simulation study on a realistic virtual population]Mor Fall, Guillaume Grenet, Hai-Ha Le, et al.
Therapie|May 19, 2020
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infectionJoëlle Micallef, Thomas Soeiro, Annie-Pierre Jonville-Béra, et al.
Therapie|March 15, 2023
Non-medical use of baclofen: A case series and review of the literatureJean-Marc Pelerin, Lisa Fristot, Valérie Gibaja, et al.
Therapie|March 14, 2023
Prescription-free consultation in France and Europe: Rates' evolution, physicians' and patients' perceptions from 2005 to 2019, a systematic reviewAmélie Richard, Bruno Mariotti, Nathalie Piñol-Domenech, et al.
Therapie|May 23, 2025
Patients under treatment for sarcoidosis reported adherence issues and would welcome personalized pharmaceutical care: Results from survey onlineCléa Dubrou, Dorian Protzenko, Aurélie S Leroyer, et al.
Therapie|July 20, 2025
Drug-induced fluorosis: A study based on the national and international pharmacovigilance databasesMyriam Mellou, Bénédicte Lelièvre, Delphine Bourneau-Martin, et al.
Therapie|May 30, 2025
[The French IRB Study: Qualification of research by ethics committees]Charles-Hervé Vacheron, Arnaud Friggeri, Maxime Lambert, et al.
Therapie|November 6, 2025
[Assessing the quality of evidence cited in French clinical practice guidelines for infectious diseases in primary care]Eulalie Gillet-Lecourt, Kenza Akhamlich, Mikaël Bouchard, et al.
Therapie|March 20, 2025
[Prevention of opioid misuse and overdose risk and distribution of naloxone: Current practices, needs and prospects among dispensing pharmacists]Armelle Chan Soc Foh, Salim Mezaache, Franck Turlure, et al.
Pageof 246